Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia.
Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
A
A
Oh
Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.|University of Illinois Cancer Center, Chicago, IL, USA.
P R
PR
Patel
Department of Pathology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
N
N
Aardsma
Department of Pathology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
S R
SR
Mehendale
Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
R
R
Chowdhery
Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
K
K
Sweiss
Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.|University of Illinois Cancer Center, Chicago, IL, USA.
D
D
Rondelli
D000328:Adult; D064591:Allografts; D000742:Anemia, Dyserythropoietic, Congenital / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D033581:Stem Cell Transplantation
D003520:Cyclophosphamide